These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2744731)

  • 1. Serial antipyrine clearance studies detect altered hepatic metabolic function during spontaneous and interferon-induced changes in chronic hepatitis B disease activity.
    Williams SJ; Farrell GC
    Hepatology; 1989 Aug; 10(2):192-7. PubMed ID: 2744731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of subchronic treatment with natural human interferons on antipyrine clearance and liver function in patients with chronic hepatitis.
    Echizen H; Ohta Y; Shirataki H; Tsukamoto K; Umeda N; Oda T; Ishizaki T
    J Clin Pharmacol; 1990 Jun; 30(6):562-7. PubMed ID: 2113064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen.
    Brunetto MR; Oliveri F; Rocca G; Criscuolo D; Chiaberge E; Capalbo M; David E; Verme G; Bonino F
    Hepatology; 1989 Aug; 10(2):198-202. PubMed ID: 2663695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term remission of chronic hepatitis B after alpha-interferon therapy.
    Korenman J; Baker B; Waggoner J; Everhart JE; Di Bisceglie AM; Hoofnagle JH
    Ann Intern Med; 1991 Apr; 114(8):629-34. PubMed ID: 2003708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of antipyrine metabolism by interferon.
    Williams SJ; Farrell GC
    Br J Clin Pharmacol; 1986 Nov; 22(5):610-2. PubMed ID: 3790409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of response to interferon in patients with chronic active hepatitis C, and evidence that this improves hepatic metabolic function.
    Farrell GC; Lin R; Coverdale S
    Gastroenterol Jpn; 1991 Jul; 26 Suppl 3():243-6. PubMed ID: 1909273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological improvement of chronic hepatitis B, and non-A, non-B with interferon treatment: application of a numerical scoring system for evaluating sequential morphologic changes.
    Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M
    Gastroenterol Jpn; 1990 Feb; 25(1):70-7. PubMed ID: 2106467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
    Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
    Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.
    Alberti A; Fattovich G; Pontisso P; Brollo L; Belussi F; Ruol A
    Chemioterapia; 1988 Dec; 7 Suppl 3():15-9. PubMed ID: 3073869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How reversible is hepatic functional impairment in autoimmune hepatitis?
    Coverdale SA; Field J; Farrell GC
    J Gastroenterol Hepatol; 2003 Apr; 18(4):371-5. PubMed ID: 12653884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of chronic hepatitis B patients treated with interferon alfa.
    Lok AS; Chung HT; Liu VW; Ma OC
    Gastroenterology; 1993 Dec; 105(6):1833-8. PubMed ID: 8253359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
    Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
    Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progression.
    Coverdale SA; Samarasinghe DA; Lin R; Kench J; Byth K; Khan MH; Crewe E; Liddle C; George J; Farrell GC
    Am J Gastroenterol; 2003 Jun; 98(6):1384-90. PubMed ID: 12818285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of metabolic function in chronic hepatitis C is related to factors associated with resistance to therapy.
    Jorquera F; Almar M; Díaz-Golpe V; Olcóz JL; García-Fernández A; González-Gallego J
    Am J Gastroenterol; 2001 Aug; 96(8):2456-61. PubMed ID: 11513190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon.
    McDonald JA; Caruso L; Karayiannis P; Scully LJ; Harris JR; Forster GE; Thomas HC
    Hepatology; 1987; 7(4):719-23. PubMed ID: 3038722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis.
    Bauer LA; O'Sullivan T; Reiss WG; Horn JR; Opheim K; Strandness DE; Carithers RL
    Br J Clin Pharmacol; 1994 Apr; 37(4):375-81. PubMed ID: 8018459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
    Bozkaya H; Ayola B; Lok AS
    Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis.
    Liaw YF; Chu CM; Su IJ; Huang MJ; Lin DY; Chang-Chien CS
    Gastroenterology; 1983 Feb; 84(2):216-9. PubMed ID: 6848402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of intrahepatic localization of hepatitis B core antigen in HBeAg positive patients with chronic active hepatitis B treated with interferon.
    Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Iwai M; Kashima K; Sokawa Y
    Am J Gastroenterol; 1990 Jun; 85(6):660-4. PubMed ID: 2191593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial.
    Perrillo RP; Regenstein FG; Peters MG; DeSchryver-Kecskemeti K; Bodicky CJ; Campbell CR; Kuhns MC
    Ann Intern Med; 1988 Jul; 109(2):95-100. PubMed ID: 3289433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.